GC CELL CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36,200 KRW | -0.28% |
|
-5.36% | -20.44% |
ETFs positioned on GC Cell Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 0 M€ | +3.95% | - |
GC Cell Corp formerly Green Cross Lab Cell Corp is a Korea-based company principally engaged in the provision of specimen testing services. The Company operates its business through four segments. The Specimen Testing Service segment provides sample testing services, clinical trial services, and veterinary testing services. The Cell Therapy segment is engaged in cell culture and technology transfer business. The Cord Blood Storage segment is engaged in the cord blood storage business. The Other Business segment is engaged in bio-logistics business and others.
Calendar
13/11/2024
- Q3 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -20.44% | 397M | |
| -16.58% | 8.49B | |
| +58.90% | 4.08B | |
| -39.78% | 2.42B | |
| -10.33% | 2.42B | |
| -8.91% | 2.33B | |
| -2.53% | 2.01B | |
| -19.90% | 1.53B | |
| -38.30% | 1.26B | |
| +2.19% | 1.07B |
- Stock Market
- Equities
- A144510 Stock
- Funds and ETFs GC Cell Corporation
